Hunter NR - Search Results

1

INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase, enhances tumor response to doxorubicin.

Mason KA, Valdecanas D, Hunter NR, Milas L. Mason KA, et al. Among authors: hunter nr. Invest New Drugs. 2008 Feb;26(1):1-5. doi: 10.1007/s10637-007-9072-5. Epub 2007 Jul 13. Invest New Drugs. 2008. PMID: 17628743

2

Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse.

Mason KA, Hunter NR, Raju U, Ariga H, Husain A, Valdecanas D, Neal R, Ang KK, Milas L. Mason KA, et al. Among authors: hunter nr. Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1181-9. doi: 10.1016/j.ijrobp.2004.03.003. Int J Radiat Oncol Biol Phys. 2004. PMID: 15234054

3

CpG oligodeoxynucleotide enhances tumor response to radiation.

Milas L, Mason KA, Ariga H, Hunter N, Neal R, Valdecanas D, Krieg AM, Whisnant JK. Milas L, et al. Cancer Res. 2004 Aug 1;64(15):5074-7. doi: 10.1158/0008-5472.CAN-04-0926. Cancer Res. 2004. PMID: 15289307

4

Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.

Mason KA, Ariga H, Neal R, Valdecanas D, Hunter N, Krieg AM, Whisnant JK, Milas L. Mason KA, et al. Clin Cancer Res. 2005 Jan 1;11(1):361-9. Clin Cancer Res. 2005. PMID: 15671567

5

CpG oligodeoxynucleotides are potent enhancers of radio- and chemoresponses of murine tumors.

Mason KA, Neal R, Hunter N, Ariga H, Ang K, Milas L. Mason KA, et al. Radiother Oncol. 2006 Aug;80(2):192-8. doi: 10.1016/j.radonc.2006.07.024. Epub 2006 Aug 14. Radiother Oncol. 2006. PMID: 16905212

6

130-nm albumin-bound paclitaxel enhances tumor radiocurability and therapeutic gain.

Wiedenmann N, Valdecanas D, Hunter N, Hyde S, Buchholz TA, Milas L, Mason KA. Wiedenmann N, et al. Clin Cancer Res. 2007 Mar 15;13(6):1868-74. doi: 10.1158/1078-0432.CCR-06-2534. Clin Cancer Res. 2007. PMID: 17363543

7

Docetaxel enhances tumor radioresponse in vivo.

Mason KA, Hunter NR, Milas M, Abbruzzese JL, Milas L. Mason KA, et al. Among authors: hunter nr. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2431-8. Clin Cancer Res. 1997. PMID: 9815644

8

Mitigation and treatment of radiation-induced thoracic injury with a cyclooxygenase-2 inhibitor, celecoxib.

Hunter NR, Valdecanas D, Liao Z, Milas L, Thames HD, Mason KA. Hunter NR, et al. Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):472-6. doi: 10.1016/j.ijrobp.2012.04.025. Epub 2012 Jun 5. Int J Radiat Oncol Biol Phys. 2013. PMID: 22672748

9

Poly(L-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurability.

Milas L, Mason KA, Hunter N, Li C, Wallace S. Milas L, et al. Int J Radiat Oncol Biol Phys. 2003 Mar 1;55(3):707-12. doi: 10.1016/s0360-3016(02)04153-6. Int J Radiat Oncol Biol Phys. 2003. PMID: 12573758

10

The epidermal growth factor receptor mediates radioresistance.

Liang K, Ang KK, Milas L, Hunter N, Fan Z. Liang K, et al. Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):246-54. doi: 10.1016/s0360-3016(03)00511-x. Int J Radiat Oncol Biol Phys. 2003. PMID: 12909240

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters